Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region

Nicholas J. Mantis, Jana Palaia, Ann Hessell, Simren Mehta, Zhiyi Zhu, Blaise Corthésy, Marian R. Neutra, Dennis R. Burton, Edward N. Janoff

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Both IgG and secretory IgA Abs in mucosal secretions have been implicated in blocking the earliest events in HIV-1 transit across epithelial barriers, although the mechanisms by which this occurs remain largely unknown. In this study, we report the production and characterization of a human rIgA2 mAb that carries the V regions of IgG1 b12, a potent and broadly neutralizing anti-gp120 Ab which has been shown to protect macaques against vaginal simian/HIV challenge. Monomeric, dimeric, polymeric, and secretory IgA 2 derivatives of b12 reacted with gp120 and neutralized CCR5- and CXCR4-tropic strains of HIV-1 in vitro. With respect to the protective effects of these Abs at mucosal surfaces, we demonstrated that IgG1 b12 and IgA 2 b12 inhibited the transfer of cell-free HIV-1 from ME-180 cells, a human cervical epithelial cell line, as well as Caco-2 cells, a human colonic epithelial cell line, to human PBMCs. Inhibition of viral transfer was due to the ability of b12 to block both viral attachment to and uptake by epithelial cells. These data demonstrate that IgG and IgA MAbs directed against a highly conserved epitope on gp120 can interfere with the earliest steps in HIV-1 transmission across mucosal surfaces, and reveal a possible mechanism by which b12 protects the vaginal mucosal against viral challenge in vivo.

Original languageEnglish (US)
Pages (from-to)3144-3152
Number of pages9
JournalJournal of Immunology
Volume179
Issue number5
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Immunoglobulin A
HIV-1
Immunoglobulin G
Epithelial Cells
Secretory Immunoglobulin A
Antibodies
Cell Line
Caco-2 Cells
Macaca
Epitopes
HIV

ASJC Scopus subject areas

  • Immunology

Cite this

Mantis, N. J., Palaia, J., Hessell, A., Mehta, S., Zhu, Z., Corthésy, B., ... Janoff, E. N. (2007). Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. Journal of Immunology, 179(5), 3144-3152.

Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. / Mantis, Nicholas J.; Palaia, Jana; Hessell, Ann; Mehta, Simren; Zhu, Zhiyi; Corthésy, Blaise; Neutra, Marian R.; Burton, Dennis R.; Janoff, Edward N.

In: Journal of Immunology, Vol. 179, No. 5, 01.09.2007, p. 3144-3152.

Research output: Contribution to journalArticle

Mantis, NJ, Palaia, J, Hessell, A, Mehta, S, Zhu, Z, Corthésy, B, Neutra, MR, Burton, DR & Janoff, EN 2007, 'Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region', Journal of Immunology, vol. 179, no. 5, pp. 3144-3152.
Mantis, Nicholas J. ; Palaia, Jana ; Hessell, Ann ; Mehta, Simren ; Zhu, Zhiyi ; Corthésy, Blaise ; Neutra, Marian R. ; Burton, Dennis R. ; Janoff, Edward N. / Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region. In: Journal of Immunology. 2007 ; Vol. 179, No. 5. pp. 3144-3152.
@article{209facaa85604b50b87506a2e1566c95,
title = "Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region",
abstract = "Both IgG and secretory IgA Abs in mucosal secretions have been implicated in blocking the earliest events in HIV-1 transit across epithelial barriers, although the mechanisms by which this occurs remain largely unknown. In this study, we report the production and characterization of a human rIgA2 mAb that carries the V regions of IgG1 b12, a potent and broadly neutralizing anti-gp120 Ab which has been shown to protect macaques against vaginal simian/HIV challenge. Monomeric, dimeric, polymeric, and secretory IgA 2 derivatives of b12 reacted with gp120 and neutralized CCR5- and CXCR4-tropic strains of HIV-1 in vitro. With respect to the protective effects of these Abs at mucosal surfaces, we demonstrated that IgG1 b12 and IgA 2 b12 inhibited the transfer of cell-free HIV-1 from ME-180 cells, a human cervical epithelial cell line, as well as Caco-2 cells, a human colonic epithelial cell line, to human PBMCs. Inhibition of viral transfer was due to the ability of b12 to block both viral attachment to and uptake by epithelial cells. These data demonstrate that IgG and IgA MAbs directed against a highly conserved epitope on gp120 can interfere with the earliest steps in HIV-1 transmission across mucosal surfaces, and reveal a possible mechanism by which b12 protects the vaginal mucosal against viral challenge in vivo.",
author = "Mantis, {Nicholas J.} and Jana Palaia and Ann Hessell and Simren Mehta and Zhiyi Zhu and Blaise Corth{\'e}sy and Neutra, {Marian R.} and Burton, {Dennis R.} and Janoff, {Edward N.}",
year = "2007",
month = "9",
day = "1",
language = "English (US)",
volume = "179",
pages = "3144--3152",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region

AU - Mantis, Nicholas J.

AU - Palaia, Jana

AU - Hessell, Ann

AU - Mehta, Simren

AU - Zhu, Zhiyi

AU - Corthésy, Blaise

AU - Neutra, Marian R.

AU - Burton, Dennis R.

AU - Janoff, Edward N.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Both IgG and secretory IgA Abs in mucosal secretions have been implicated in blocking the earliest events in HIV-1 transit across epithelial barriers, although the mechanisms by which this occurs remain largely unknown. In this study, we report the production and characterization of a human rIgA2 mAb that carries the V regions of IgG1 b12, a potent and broadly neutralizing anti-gp120 Ab which has been shown to protect macaques against vaginal simian/HIV challenge. Monomeric, dimeric, polymeric, and secretory IgA 2 derivatives of b12 reacted with gp120 and neutralized CCR5- and CXCR4-tropic strains of HIV-1 in vitro. With respect to the protective effects of these Abs at mucosal surfaces, we demonstrated that IgG1 b12 and IgA 2 b12 inhibited the transfer of cell-free HIV-1 from ME-180 cells, a human cervical epithelial cell line, as well as Caco-2 cells, a human colonic epithelial cell line, to human PBMCs. Inhibition of viral transfer was due to the ability of b12 to block both viral attachment to and uptake by epithelial cells. These data demonstrate that IgG and IgA MAbs directed against a highly conserved epitope on gp120 can interfere with the earliest steps in HIV-1 transmission across mucosal surfaces, and reveal a possible mechanism by which b12 protects the vaginal mucosal against viral challenge in vivo.

AB - Both IgG and secretory IgA Abs in mucosal secretions have been implicated in blocking the earliest events in HIV-1 transit across epithelial barriers, although the mechanisms by which this occurs remain largely unknown. In this study, we report the production and characterization of a human rIgA2 mAb that carries the V regions of IgG1 b12, a potent and broadly neutralizing anti-gp120 Ab which has been shown to protect macaques against vaginal simian/HIV challenge. Monomeric, dimeric, polymeric, and secretory IgA 2 derivatives of b12 reacted with gp120 and neutralized CCR5- and CXCR4-tropic strains of HIV-1 in vitro. With respect to the protective effects of these Abs at mucosal surfaces, we demonstrated that IgG1 b12 and IgA 2 b12 inhibited the transfer of cell-free HIV-1 from ME-180 cells, a human cervical epithelial cell line, as well as Caco-2 cells, a human colonic epithelial cell line, to human PBMCs. Inhibition of viral transfer was due to the ability of b12 to block both viral attachment to and uptake by epithelial cells. These data demonstrate that IgG and IgA MAbs directed against a highly conserved epitope on gp120 can interfere with the earliest steps in HIV-1 transmission across mucosal surfaces, and reveal a possible mechanism by which b12 protects the vaginal mucosal against viral challenge in vivo.

UR - http://www.scopus.com/inward/record.url?scp=38449097264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449097264&partnerID=8YFLogxK

M3 - Article

C2 - 17709529

AN - SCOPUS:38449097264

VL - 179

SP - 3144

EP - 3152

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -